How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?
How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?
Aim: Thyroidal incidentalomas (Tis) detected by F-18 fluorodeoxyglucose positron emission tomography/computed tomography(F-18FDG PET/CT) may be associated with three different causes that include metastasis of another malignancy, primary thyroidgland malignancies and lastly benign thyroidal nodules, all require different clinical approaches. For appropriate treatment, quickcharacterization of the Ti is important, preferably with a lesser invasive method. Our aim was to determine whether the characterizationof TIs can be performed with FDG-PET/CT, due to contribute faster diagnosis, and initiation of the therapy.Material and Methods: Forty-four patients with detected TIs in FDG-PET/CT were included in the study. The relationship betweenmetabolically/morphological parameters and pathology results were evaluated statistically. If two subsequent cytology werenegative, nodule accepted as benign. If cytology result was suspected or malignant, histopathological confirmation was made. Forthese patients, histopathological results were accepted as definite diagnosis.Results: Malignant thyroidal pathologies were detected in 29.5% of patients. We could not find any significant relationship betweenage, nodule size and SUVmax value and pathology results. According to ROC analysis, there were not any cut-off value for nodulesize and SUVmax. Similar results were also obtained for papillary carcinoma as a special subgroup.Conclusion: Characterisation of TIs could not be performed by using age, nodule size and SUVmax. Therefore, TIs which detected byFDG-PET/CT should be examined pathologically due to high risk of malignancy.
___
- 1. Reum CA, Min JH, Ho LS, et al. Risk of malignancy in thyroid
incidentalomas identified by fluorodeoxyglucose-positron
emission tomography endocrinol metab 2015;30:71-7.
- 2. Tan GH, Gharib H. Thyroid incidentalomas: management
approaches to nonpalpable nodules discovered incidentally
on thyroid imaging. Ann Intern Med 1997;126:226–31
- 3. Mortensen JD, Woolner LB, Bennett WA. Gross and
microscopic findings in clinically normal thyroid glands. J
Clin Endocrinol Metab 1955;15:1270–80.
- 4. Iyer NG, Shaha AR. Management of Thyroid Nodules and
Surgery for Differentiated Thyroid Cancer. Clin Oncol
2010;22:405-12.
- 5. Lawal IO, Nyakale NE, Harry LM et al. Higher preablative
serum thyroid stimulating hormone level predicts radioiodine
ablation effectiveness in patients with differentiated thyroid
carcinoma. Nucl Med Commun 2017;38:222-7.3.
- 6. Dean DS, Gharib H. Epidemiology of Thyroid Nodules. Best
Prac Res Clin Endocrin Metab 2008;22:901-11.
- 7. Lonsdale MN, Beyer T. Dual-modality PET/CT
instrumentation: today and tomorrow. Eur J Radiol
2010;73:452–60.
- 8. Kresnik E, Gallowitsch HJ, Mikosch P, et al. Fluorine-18-
fluorodeoxyglucose positron emission tomography in the
preoperative assessment of thyroid nodules in an endemic
goiter area. Surgery 2003;133:29.
- 9. Chen YK, Ding HJ, Chen KT, et al. Prevalence and risk
of cancer of focal thyroid incidentaloma identified by
f-fluorodeoxyglucose positron emission tomography for
cancer screening in healthy subjects antıcancer research
2005;25:1421-6.
- 10. Bertagna F, Treglia G, Piccardo A, et al. Diagnostic and clinical
significance of F-18-FDG-PET/CT thyroid incidentalomas.
J Clin Endocrinol Metab 2012;97:3866-7.
- 11. Nam SY, Roh JL, Kim JS, et al. Focal uptake of 18F
fluorodeoxyglucose by thyroid in patients with nonthyroidal
head and neck cancers. Clin Endocrinol 2007;67:135–9.
- 12. Lee WM, BJ Kim, Kim MH, et al. Characteristics of thyroid
incidentalomas detected by pre-treatment [18F]FDG PET
or PET/CT in patients with cervical cancer J Gynecol Oncol
2012;23:43-7.
- 13. Albes JM, Dohmen BM, Schott U, et al. Value of positron
emission tomography for lung cancer staging. Eur J Surg
Oncol 2002;28:55–62.
- 14. Hegedus L. Clinical practice: the thyroid nodule. N Engl J
Med 2004;351:1764-71.
- 15. Yaylali O, Kirac FS, Yuksel D, et al. Evaluation of focal
thyroid lesions incidentally detected in fluorine-18-
fluorodeoxyglucose positron emission tomography/
computed tomography images. Indian J Cancer
2014;51:236-40.
- 16. Kim TY, Kim WB, Ryu JS, et al. 18Ffluorodeoxyglucose
uptake in thyroid from positron emission tomography
(PET) for evaluation in cancer patients: high prevalence of
malignancy in thyroid PET incidentaloma. Laryngoscope
2005;115:1074–8.
- 17. Sinae L, Taegyu P, Soyeon P, et al. The Clinical Role of Dual-
Time-Point 18F-FDG PET/CT in Differential Diagnosis
of theThyroid Incidentaloma Nucl Med Mol Imaging
2014;48:121–9.
- 18. Jamsek J, Zagar I, Gaberscek S, et al. Thyroid lesions
incidentally detected by 18F-FDG PET-CT ― a two centre
retrospective study Radiol Oncol 2015;49:121.
- 19. Kim BH, Kim SJ, Kim H, et al. Diagnostic value of metabolic
tumor volume assessed by 18F-FDG PET/CT added
to SUVmax for characterization of thyroid 18F-FDG
incidentaloma Nuclear Medicine Communications
2013;34;868–76.
- 20. Soelberg KK, Bonnema SJ, Brix TH, et al. Risk of
malignancy in thyroid incidentalomas detected by
18F-fluorodeoxyglucose positron emission tomography: a
systematic review. Thyroid 2012; 22:918–25.
- 21. Kim BH, Na MA, Kim IJ, et al. Risk stratification and prediction
of cancer of focal thyroid fluorodeoxyglucose uptake during
cancer evaluation Ann Nucl Med 2010;24:721–8.
- 22. Kim H, Seong-Jang K, Kim IJ, et al. Thyroid Incidentalomas
on FDG PET/CT in Patients with Non-Thyroid Cancer a Large
Retrospective Monocentric Study Onkologie 2013;36:260–
4.
- 23. Adas M, Adas G, Koc B, et al . Incidental thyroid lesions.
on FDG-PET/CT: a prevalence study and proposition of
management Minerva Endocrinologica 2015;40:169-75.
- 24. Pagano L, Sama MT, Morani F, et al. Thyroid incidentaloma
identified by 18F fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological
relevance Clinical Endocrinology 2011;75,528-34.
- 25. Shie P, Cardarelli R, Sprawls K, et al. Systematic review:
prevalence of malignant incidental thyroid nodules
identified on fluorine-18 fluorodeoxyglucose positron
emission tomography. Nucl Med Comm 2009;30:742-748.
- 26. Kang KW, Kim SK, Kang HS, et al. Prevalence and risk
of cancer of focal thyroid incidentaloma identified by
18F-fluorodeoxyglucose positron emission tomography
for metastasis evaluation and cancer screening in healthy
subjects. J Clin Endocrinol Metab 2003;88:4100-4.
- 27. Choi JW, Yoon YH, Yoon YH,et al. Characteristics of primary
papillary thyroid carcinoma with false-negative findings on
initial (18)F-FDG PET/CT. Ann Surg Oncol 2011;18:1306-11.
- 28. Di Pasquale M, Rothstein JL, Palazzo JP. Pathologic features
of Hashimoto’s associated papillary thyroid carcinoma.
Human Pathology 2001;32,24-30.
- 29. Ohba K, Nishizawa S, Matsushita A, et al. High incidence of
thyroid cancer in focal thyroid incidentaloma detected by
18F-fluorodexyglucose positron emission tomography in
relatively young healthy subjects: results of 3-year followup
Endocrine Journal 2010,57, 395-401.
- 30. Kim MJ, Kim EK, Park SI, et al. US-guided fine-needle
aspiration of thyroid nodules: indications, techniques,
results. Radiographics 2008; 28:1869-86.